Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tang Capital Partners
Biotech
Concentra strikes again, circling up IGM Biosciences
Concentra Biosciences continues to scavenge for struggling biotechs, this time picking up antibody biotech IGM Biosciences for $1.25 per share.
Gabrielle Masson
Jul 1, 2025 9:58am
Embattled Elevation is latest biotech to accept Concentra buyout
Jun 9, 2025 10:25am
Concentra swoops in to purchase struggling Kronos
May 1, 2025 3:07pm
Concentra scoops up near-defunct Allakos
Apr 2, 2025 5:05pm
Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms
Mar 14, 2025 10:01am
Acelyrin turns down surprise Concentra buyout offer
Mar 4, 2025 10:26am
